Amicus Therapeutics Inc
FOLD
ISIN null / Valor 2644388
Amicus Therapeutics Inc
UMushroom community rating:
About company
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes therapies for rare genetic diseases, with a particular focus on lysosomal storage disorders; its marketed product is migalastat (Galafold), an oral pharmacological chaperone for patients with amenable mutations in Fabry disease, and its pipeline includes next‑generation enzyme replacement approaches, chaperone-ERT combination strategies, small-molecule programs and gene therapy candidates aimed at conditions such as Pompe disease and other inherited metabolic disorders. The company conducts clinical development and regulatory activities across major markets, supports commercialization of approved products, and seeks to advance earlier-stage assets through internal R&D and external collaborations to generate revenue and potential future approvals.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
4525 M
Market cap (USD)
2,288,924
Daily traded volume (Shares)
9.57 / 9.33
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
